| The Wall Street Journal Western Edition 1998 Rhonda L. Rundle |
| Title | Subject | Authors |
|---|
| Agouron to buy certain rights to immune response AIDS drug. | Business, general | Rhonda L. Rundle |
| Amgen abandons development work on clotting drug. | Business, general | Rhonda L. Rundle |
| Amgen gets shot in the arm from arbitrators' ruling; award of sole rights to anemia drug sends company's shares soaring.(Abstract) | Business, general | Rhonda L. Rundle |
| Amgen, J&J feud over hot anemia drug. | Business, general | Rhonda L. Rundle |
| Amgen wins rights to sell anemia drug.(Abstract) | Business, general | Rhonda L. Rundle |
| Apria switches outside auditors in major reshuffle. | Business, general | Rhonda L. Rundle |
| Entergy Chairman Lupberger resigns; Luft fills positions pending a search. | Business, general | Kathryn Kranhold, Rhonda L. Rundle |
| Entergy's $80 million offer for Pilgrim beats out rival Peco for nuclear plant.(Abstract) | Business, general | Kathryn Kranhold, Rhonda L. Rundle |
| FPA Medical stops paying its doctors in parts of 3 states. | Business, general | Rhonda L. Rundle |
| FPA's CEO received salary increase five days before Chapter 11 filing. | Business, general | Rhonda L. Rundle |
| Hilton cites Asia in profit warning for 3rd quarter. | Business, general | Rhonda L. Rundle |
| PacifiCare offers medical-quality index. | Business, general | Rhonda L. Rundle |
| Tenet Healthcare probes focuses on Florida Deals. | Business, general | Rhonda L. Rundle |
| WellPoint set to buy Georgia medical firm. | Business, general | Rhonda L. Rundle |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
